Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.
PrivateLast Round
Strategic
Oct 16, 2025
Total Funding Raised
$37.08M
Company Overview
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a VC Round in June 2021.
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. is a biotechnology company that specializes in the research, development, and industrialization of cell and gene therapies, including CAR-T and CAR-NK drugs for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. Comparables
Compare Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chongqing Precision Biotech Co., Ltd. | 90% | |
| Juventas Cell Therapy Ltd. | 88% | |
| Shanghai YaKe Biotechnology Co., Ltd. | 87% |
For institutional investors. Book with your work email.
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 16, 2025 | ||||
| VC Round | Jun 7, 2021 | ||||
| VC Round | Jun 3, 2021 | ||||
| Series B | Nov 16, 2020 | ||||
| Series A | Apr 1, 2018 | ||||
Pre Seed | May 1, 2017 |
For institutional investors. Book with your work email.
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guoke Jiahe Capital | Series B, Series A |
| Shenzhen Guozhong Venture Capital Management | Series A |
| Hunan High-tech Venture Capital Group Co., Ltd. | Series B |
| Shenzhen Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
$120M raised, led by Kite Pharma.
- Jun 7, 2021
Completed a VC Round funding round.
For institutional investors. Book with your work email.
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. a public or private company?
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.?
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. worth (valuation)?
Valuation information for Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. is not publicly available.
Can I buy Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. stock?
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.'s last funding round?
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.'s most recent funding round was Strategic on October 16, 2025.
Who are the main investors in Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.?
Key investors in Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. include Guoke Jiahe Capital.
Will Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen Pregene Bio-Pharmaceutical Co., Ltd..
How can I track Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.'s shares on secondary markets.